Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 132,526 | 54,126 | 35,944 | 56,984 | 39,029 |
| Marketable Securities | 250,928 | 257,221 | 136,653 | 101,981 | 119,138 |
| Receivables | 38,000 | 31,658 | 29,937 | 25,855 | 22,366 |
| Inventories | 48,569 | 41,411 | 31,278 | 61,645 | 29,263 |
| TOTAL | $477,969 | $391,110 | $243,089 | $252,582 | $214,257 |
| Non-Current Assets | |||||
| PPE Net | 108,670 | 107,046 | 101,016 | 90,324 | 60,632 |
| Investments And Advances | 40,674 | 74,193 | 0 | 13,462 | 24,431 |
| Intangibles | 62,040 | 55,197 | 46,737 | 30,961 | 24,164 |
| Other Non-Current Assets | 0 | 825 | 624 | 406 | 2,588 |
| TOTAL | $211,384 | $237,261 | $148,377 | $135,153 | $111,815 |
| Total Assets | $689,353 | $628,371 | $391,466 | $387,735 | $326,072 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,368 | 14,658 | 7,511 | 8,739 | 6,758 |
| Accrued Expenses | 45,865 | 41,057 | 36,666 | 35,375 | 28,311 |
| Other current liabilities | N/A | N/A | N/A | N/A | 276 |
| TOTAL | $60,661 | $56,217 | $44,838 | $149,788 | $140,010 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 102 | 595 | 1,426 | 1,426 |
| Other Non-Current Liabilities | 307,466 | 292,671 | 127,652 | 11,473 | 5,409 |
| TOTAL | $307,466 | $292,671 | $127,652 | $19,555 | $14,917 |
| Total Liabilities | $368,127 | $348,888 | $172,490 | $169,343 | $154,927 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,230 | 40,712 | 37,525 | 37,053 | 36,236 |
| Common Shares | 41 | 41 | 37 | 37 | 36 |
| Retained earnings | -388,226 | -389,136 | -346,238 | -308,289 | -310,145 |
| Other shareholders' equity | -280 | -454 | -30 | -52 | -80 |
| TOTAL | $321,226 | $279,483 | $218,976 | $218,392 | $171,145 |
| Total Liabilities And Equity | $689,353 | $628,371 | $391,466 | $387,735 | $326,072 |